Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 20:12:37 UTC
Update Date2021-09-26 23:15:34 UTC
HMDB IDHMDB0258572
Secondary Accession NumbersNone
Metabolite Identification
Common NameSulfachlorpyridazine
DescriptionSulfachlorpyridazine, also known as SCP or nefrosul, belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. Based on a literature review a significant number of articles have been published on Sulfachlorpyridazine. This compound has been identified in human blood as reported by (PMID: 31557052 ). Sulfachlorpyridazine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Sulfachlorpyridazine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
4-Amino-N-(6-chloro-3-pyridazinyl)benzenesulfonamideChEBI
4-Amino-N-(6-chloropyridazin-3-yl)benzenesulfonamideChEBI
N1-(6-Chloro-3-pyridazinyl)sulfanilamideChEBI
SCPChEBI
SulfachlorpyridazinumChEBI
SulfacloropiridazinaChEBI
SulphachlorpyridazineChEBI
NefrosulKegg
4-Amino-N-(6-chloro-3-pyridazinyl)benzenesulphonamideGenerator
4-Amino-N-(6-chloropyridazin-3-yl)benzenesulphonamideGenerator
N1-(6-Chloro-3-pyridazinyl)sulphanilamideGenerator
SulphachlorpyridazinumGenerator
SulphacloropiridazinaGenerator
SulfachlorpyridazineChEBI
SulphachloropyridazineGenerator
Monosodium salt sulfachlorpyridazineMeSH
Sulfachlorpyridazine, monosodium saltMeSH
Chemical FormulaC10H9ClN4O2S
Average Molecular Weight284.72
Monoisotopic Molecular Weight284.0134744
IUPAC Name4-amino-N-(6-chloropyridazin-3-yl)benzene-1-sulfonamide
Traditional Namesulfachloropyridazine
CAS Registry NumberNot Available
SMILES
NC1=CC=C(C=C1)S(=O)(=O)NC1=NN=C(Cl)C=C1
InChI Identifier
InChI=1S/C10H9ClN4O2S/c11-9-5-6-10(14-13-9)15-18(16,17)8-3-1-7(12)2-4-8/h1-6H,12H2,(H,14,15)
InChI KeyXOXHILFPRYWFOD-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzenesulfonamides
Direct ParentAminobenzenesulfonamides
Alternative Parents
Substituents
  • Aminobenzenesulfonamide
  • Benzenesulfonyl group
  • Aniline or substituted anilines
  • Aryl chloride
  • Aryl halide
  • Pyridazine
  • Organosulfonic acid amide
  • Imidolactam
  • Organic sulfonic acid or derivatives
  • Heteroaromatic compound
  • Organosulfonic acid or derivatives
  • Aminosulfonyl compound
  • Sulfonyl
  • Azacycle
  • Organoheterocyclic compound
  • Hydrocarbon derivative
  • Organic oxide
  • Primary amine
  • Organosulfur compound
  • Organonitrogen compound
  • Organochloride
  • Organohalogen compound
  • Organopnictogen compound
  • Organic oxygen compound
  • Amine
  • Organic nitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP0.97ALOGPS
logP0.85ChemAxon
logS-3.3ALOGPS
pKa (Strongest Acidic)6.6ChemAxon
pKa (Strongest Basic)2.02ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area97.97 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity71.48 m³·mol⁻¹ChemAxon
Polarizability25.94 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+165.74330932474
DeepCCS[M-H]-163.38530932474
DeepCCS[M-2H]-196.27130932474
DeepCCS[M+Na]+171.83630932474
AllCCS[M+H]+162.732859911
AllCCS[M+H-H2O]+159.132859911
AllCCS[M+NH4]+166.032859911
AllCCS[M+Na]+166.932859911
AllCCS[M-H]-157.232859911
AllCCS[M+Na-2H]-157.132859911
AllCCS[M+HCOO]-157.232859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
SulfachlorpyridazineNC1=CC=C(C=C1)S(=O)(=O)NC1=NN=C(Cl)C=C14165.4Standard polar33892256
SulfachlorpyridazineNC1=CC=C(C=C1)S(=O)(=O)NC1=NN=C(Cl)C=C12776.6Standard non polar33892256
SulfachlorpyridazineNC1=CC=C(C=C1)S(=O)(=O)NC1=NN=C(Cl)C=C12863.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Sulfachlorpyridazine,1TMS,isomer #1C[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C12947.4Semi standard non polar33892256
Sulfachlorpyridazine,1TMS,isomer #1C[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C12640.7Standard non polar33892256
Sulfachlorpyridazine,1TMS,isomer #1C[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C13863.6Standard polar33892256
Sulfachlorpyridazine,1TMS,isomer #2C[Si](C)(C)N(C1=CC=C(Cl)N=N1)S(=O)(=O)C1=CC=C(N)C=C12684.6Semi standard non polar33892256
Sulfachlorpyridazine,1TMS,isomer #2C[Si](C)(C)N(C1=CC=C(Cl)N=N1)S(=O)(=O)C1=CC=C(N)C=C12582.6Standard non polar33892256
Sulfachlorpyridazine,1TMS,isomer #2C[Si](C)(C)N(C1=CC=C(Cl)N=N1)S(=O)(=O)C1=CC=C(N)C=C14026.2Standard polar33892256
Sulfachlorpyridazine,2TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C1)[Si](C)(C)C2679.4Semi standard non polar33892256
Sulfachlorpyridazine,2TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C1)[Si](C)(C)C2705.7Standard non polar33892256
Sulfachlorpyridazine,2TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C1)[Si](C)(C)C3602.9Standard polar33892256
Sulfachlorpyridazine,2TMS,isomer #2C[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C)C=C12713.2Semi standard non polar33892256
Sulfachlorpyridazine,2TMS,isomer #2C[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C)C=C12704.5Standard non polar33892256
Sulfachlorpyridazine,2TMS,isomer #2C[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C)C=C13445.0Standard polar33892256
Sulfachlorpyridazine,3TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C)C=C1)[Si](C)(C)C2598.4Semi standard non polar33892256
Sulfachlorpyridazine,3TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C)C=C1)[Si](C)(C)C2797.7Standard non polar33892256
Sulfachlorpyridazine,3TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C)C=C1)[Si](C)(C)C3258.1Standard polar33892256
Sulfachlorpyridazine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C13187.8Semi standard non polar33892256
Sulfachlorpyridazine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C12873.1Standard non polar33892256
Sulfachlorpyridazine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C13861.2Standard polar33892256
Sulfachlorpyridazine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=CC=C(Cl)N=N1)S(=O)(=O)C1=CC=C(N)C=C12964.9Semi standard non polar33892256
Sulfachlorpyridazine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=CC=C(Cl)N=N1)S(=O)(=O)C1=CC=C(N)C=C12806.2Standard non polar33892256
Sulfachlorpyridazine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=CC=C(Cl)N=N1)S(=O)(=O)C1=CC=C(N)C=C13981.4Standard polar33892256
Sulfachlorpyridazine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C1)[Si](C)(C)C(C)(C)C3226.5Semi standard non polar33892256
Sulfachlorpyridazine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C1)[Si](C)(C)C(C)(C)C3141.3Standard non polar33892256
Sulfachlorpyridazine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=CC=C(Cl)N=N2)C=C1)[Si](C)(C)C(C)(C)C3569.1Standard polar33892256
Sulfachlorpyridazine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C(C)(C)C)C=C13214.6Semi standard non polar33892256
Sulfachlorpyridazine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C(C)(C)C)C=C13151.8Standard non polar33892256
Sulfachlorpyridazine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C(C)(C)C)C=C13493.9Standard polar33892256
Sulfachlorpyridazine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3334.5Semi standard non polar33892256
Sulfachlorpyridazine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3450.6Standard non polar33892256
Sulfachlorpyridazine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=CC=C(Cl)N=N2)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3386.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Sulfachlorpyridazine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a7l-9530000000-2e028c198faa7e31bd962021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Sulfachlorpyridazine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfachlorpyridazine LC-ESI-QTOF , positive-QTOFsplash10-0a4i-1900000000-d2bc1c887f6f99ed0f742017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfachlorpyridazine -1V, Positive-QTOFsplash10-0a4i-1900000000-7e06e82630b18b9f346a2021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfachlorpyridazine 10V, Positive-QTOFsplash10-000i-0390000000-c8c99496cea5c83c1f0c2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfachlorpyridazine 20V, Positive-QTOFsplash10-0a4i-0920000000-4be4169d4251aa5f1a4f2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfachlorpyridazine 40V, Positive-QTOFsplash10-00o9-9400000000-b50f825fd23371d2eace2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfachlorpyridazine 10V, Negative-QTOFsplash10-001i-0090000000-edf87b11590d410c35a92016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfachlorpyridazine 20V, Negative-QTOFsplash10-001i-1490000000-aeb37a69a3d8e826e5702016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfachlorpyridazine 40V, Negative-QTOFsplash10-0007-9610000000-3465b893bdde4e1cb8c62016-08-03Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11461
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID6382
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkSulfachlorpyridazine
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID59057
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]